Cancer Research Programs
Cedars-Sinai Cancer has fostered the development of three research programs derived from our institutional strengths and priorities. As an emerging institute, we have concentrated efforts and resources to make the programs successful, well-funded, and interactive with each other, rather than attempting to nurture multiple possible programs.
Cedars-Sinai Cancer supports three programs, oriented toward cancer biology, experimental therapeutics, and cancer prevention and control studies.
This program represents the only coordinated, multi-investigator effort in the nation to focus on the causes of and approaches to address liver metastasis from cancers of the prostate, pancreas and colon. The four integrated projects point to key roles for critical molecular signaling axes in mediating liver metastasis, through mechanisms likely common across many tumor types. The clinical capabilities across oncology and hepatology will enable translation of the mechanistic findings.